XML 18 R8.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Impact of Adopting CECL (ASU 2016-13)
Stock Options
Common Stock
Common Stock
Stock Options
Retained Earnings
Retained Earnings
Impact of Adopting CECL (ASU 2016-13)
Accumulated Other Compre-hensive Income (Loss)
Balance at beginning of period (in shares) at Sep. 30, 2022       8,221,952        
Balance at beginning of period at Sep. 30, 2022 $ 218,569     $ 38,751   $ 180,535   $ (717) [1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 20,476         20,476    
Other comprehensive loss (27)             (27)
Repurchase of common stock (in shares)       (154,833)        
Repurchase of common stock $ (4,119)     $ (4,119)        
Exercise of stock options (in shares) 27,055     27,055        
Exercise of stock options $ 534     $ 534        
Common stock dividends (6,405)         (6,405)    
Stock-based compensation expense     $ 235   $ 235      
Balance at end of period (in shares) at Jun. 30, 2023       8,094,174        
Balance at end of period at Jun. 30, 2023 229,263     $ 35,401   194,606   (744) [1]
Balance at beginning of period (in shares) at Mar. 31, 2023       8,203,174        
Balance at beginning of period at Mar. 31, 2023 227,661     $ 37,979   190,177   (495) [1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 6,306         6,306    
Other comprehensive loss (249)             (249)
Repurchase of common stock (in shares)       (110,000)        
Repurchase of common stock (2,674)     $ (2,674)        
Exercise of stock options (in shares)       1,000        
Exercise of stock options 17     $ 17        
Common stock dividends (1,877)         (1,877)    
Stock-based compensation expense     79   79      
Balance at end of period (in shares) at Jun. 30, 2023       8,094,174        
Balance at end of period at Jun. 30, 2023 229,263     $ 35,401   194,606   (744) [1]
Balance at beginning of period (in shares) at Sep. 30, 2023       8,105,338        
Balance at beginning of period at Sep. 30, 2023 233,073 [2]     $ 34,771   199,386   (1,084) [1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 17,928         17,928    
Other comprehensive loss 539             539
Repurchase of common stock (in shares)       (182,117)        
Repurchase of common stock $ (4,801)     $ (4,801)        
Exercise of stock options (in shares) 30,200     30,200        
Exercise of stock options $ 395     $ 395        
Common stock dividends (5,739)         (5,739)    
Stock-based compensation expense     316   316      
Balance at end of period (in shares) at Jun. 30, 2024       7,953,421        
Balance at end of period at Jun. 30, 2024 241,223 $ (488)   $ 30,681   211,087 $ (488) (545) [1]
Balance at beginning of period (in shares) at Mar. 31, 2024       8,023,121        
Balance at beginning of period at Mar. 31, 2024 238,679     $ 32,338   207,086   (745) [1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 5,924         5,924    
Other comprehensive loss 200             200
Repurchase of common stock (in shares)       (70,000)        
Repurchase of common stock (1,767)     $ (1,767)        
Exercise of stock options (in shares)       300        
Exercise of stock options 5     $ 5        
Common stock dividends (1,923)         (1,923)    
Stock-based compensation expense     $ 105   $ 105      
Balance at end of period (in shares) at Jun. 30, 2024       7,953,421        
Balance at end of period at Jun. 30, 2024 $ 241,223 $ (488)   $ 30,681   $ 211,087 $ (488) $ (545) [1]
[1] All amounts are net of income taxes.
[2] Derived from audited consolidated financial statements.